Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jun 2026 for NEKTAR THERAPEUTICS, €325k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Jonathan Zalevsky: trading record in brief
All filings by Jonathan Zalevsky on record concern Nektar Therapeutics. Between 15 June 2026 and 30 June 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 30 June 2026: a transaction of €325k, in Nektar Therapeutics. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jonathan Zalevsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
5,681 shares@ US$65.390.019% mcap53.4% of flowCommonSEC144:0001950047-26-006656
5,538 shares@ US$59.380.014% mcap46.6% of flowCommonSEC144:0001950047-26-006135
2 of 2 declarations
